Matthew Gline - Net Worth and Insider Trading
Matthew Gline Net Worth
The estimated net worth of Matthew Gline is at least $14 Million dollars as of 2024-09-20. Matthew Gline is the CEO of Roivant Sciences Ltd and owns about 1,164,009 shares of Roivant Sciences Ltd (ROIV) stock worth over $14 Million. Details can be seen in Matthew Gline's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Gline has not made any transactions after 2022-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Gline
Matthew Gline Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Gline owns 1 companies in total, including Roivant Sciences Ltd (ROIV) .
Click here to see the complete history of Matthew Gline’s form 4 insider trades.
Insider Ownership Summary of Matthew Gline
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ROIV | Roivant Sciences Ltd | 2022-10-25 | director & CEO |
Matthew Gline Latest Holdings Summary
Matthew Gline currently owns a total of 1 stock. Matthew Gline owns 1,164,009 shares of Roivant Sciences Ltd (ROIV) as of October 25, 2022, with a value of $14 Million.
Latest Holdings of Matthew Gline
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd | 2022-10-25 | 1,164,009 | 11.97 | 13,927,368 |
Holding Weightings of Matthew Gline
Matthew Gline Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Gline has made a total of 11 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 19,276 shares on October 25, 2022, which brought Matthew Gline around $84,814.
Insider Trading History of Matthew Gline
- 1
Matthew Gline Trading Performance
Matthew Gline Ownership Network
Matthew Gline Owned Company Details
What does Roivant Sciences Ltd do?
Who are the key executives at Roivant Sciences Ltd?
Matthew Gline is the director & CEO of Roivant Sciences Ltd. Other key executives at Roivant Sciences Ltd include President & COO Eric Venker , 10 percent owner Svf Investments (uk) Ltd , and 10 percent owner & other: Director by Deputization Qvt Financial Lp .
Roivant Sciences Ltd (ROIV) Insider Trades Summary
Over the past 18 months, Matthew Gline made no insider transaction in Roivant Sciences Ltd (ROIV). Other recent insider transactions involving Roivant Sciences Ltd (ROIV) include a net sale of 3,996,950 shares made by Eric Venker , a net sale of 458,143 shares made by Rakhi Kumar , and a net sale of 15,116,277 shares made by Sumitomo Chemical Co., Ltd. .
In summary, during the past 3 months, insiders sold 0 shares of Roivant Sciences Ltd (ROIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 82,467,514 shares of Roivant Sciences Ltd (ROIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 82,467,514 shares.
Roivant Sciences Ltd (ROIV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Roivant Sciences Ltd Insider Transactions
Matthew Gline Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Gline. You might contact Matthew Gline via mailing address: C/o Urovant Sciences, Inc., 5151 California Avenue, Suite 250, Irvine Ca 92617.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
